Prelude Capital Management, LLC Exagen Inc. Transaction History
Prelude Capital Management, LLC
- $1.39 Billion
- Q2 2024
Shares
4 transactions
Others Institutions Holding XGN
# of Institutions
37Shares Held
6.29MCall Options Held
2.5KPut Options Held
200-
Rtw Investments, LP New York, NY1.51MShares$4.48 Million0.05% of portfolio
-
Cowen And Company, LLC891KShares$2.64 Million0.04% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT762KShares$2.26 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY545KShares$1.61 Million0.01% of portfolio
-
Perkins Capital Management Inc493KShares$1.46 Million0.88% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $48.1M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...